Top Selling Biologics Market, 2021-2030

  Roots Analysis has announced the addition of Telemedicine Tools and Software Providers Market report to its list of offerings.   The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices. The concept of monitoring patients over telephone can be traced back to the 1800’s. However, it was not until 1961, during the National Aeronautics and Space Administration (NASA) space mission, when remote physiologic monitoring of astronauts was efficiently required. Further, with the introduction of cloud computing in 1960s, the remote patient monitoring domain evolved at a significant pace, as these solutions were capable of enabling information sharing and analysis to carry out the process in a more robust manner. Since then, the domain has gained more popularity amongst patients and their caregivers owing to ease of use and cost-effectiveness.     To request a sample copy / brochure of t...

  Roots Analysis  has announced the addition of  Top Selling Biologics Market, 2021-2030  report to its list of offerings.   As of today, most of the top revenue generating drugs, across the globe, are biologics. During our research, we were able to identify 67 top selling  biologics  (revenues equal to or above USD 500 million in 2020).   To request a sample copy / brochure of this report, please visit this:   https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html   Top selling biologics market has so far been primarily led by industry players. Majority of industry players have taken a step towards investing their time and resources for the development of biologic therapies. Genentech, Amgen, Janssen Biotech, Sanofi and Novo Nordisk are amongst the major players in this domain. Biogen, AstraZeneca, Merck, Bristol Myers Squibb, GlaxoSmithKline, Alexion Pharmaceuticals, AbbVie and Novarti...